ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0211

Characteristics of Hospitalizations and Outpatient Follow-up for Patients with SLE at an Academic Hospital Setting in Austin, Texas

Riti Kotamarti1 and Veena Patel2, 1Dell Seton Medical Center, Austin, TX, 2Dell Medical School - UT Health Austin, Austin, TX

Meeting: ACR Convergence 2024

Keywords: Access to care, Demographics, Health Care, quality of care, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Health Services Research – ACR/ARP Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with SLE have high rates of hospitalizations annually and require careful coordination of care in both the inpatient and outpatient setting. Prior analyses have shown how SLE patients from disadvantaged socioeconomic backgrounds are more likely to have multiple hospital admissions in comparison to their counterparts.1 In our own hospital system in Austin, Texas, almost half of our patients are uninsured or underinsured. The purpose of this project was to review the characteristics of hospital admissions of SLE patients in our hospital system and follow these patients’ transitions of care by reviewing outpatient rheumatology records.


  1.  Yazdany, J., Marafino, B. J., Dean, M. L., Bardach, N. S., Duseja, R., Ward, M. M., & Dudley, R. A. (2014). Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation. Arthritis & Rheumatology, 66(10), 2828–2836. doi:10.1002/art.38768

Methods: Using Vizient database, we retrospectively reviewed patients hospitalized at Dell Seton Medical Center in Austin, Texas from 2020 – 2022 with an ICD-10 diagnosis code of SLE. We collected demographic data, information about the hospitalization and any subsequent admissions. For patients who were recommended rheumatology follow-up on discharge paperwork, we reviewed the chart records of our three outpatient rheumatology clinic sites to determine if patients attended their follow-up appointments. 

Results: There were 125 admissions with an ICD diagnosis of SLE. 18 of these patients do not have a proven SLE diagnosis and were excluded. 

 

Of the 107 identified patients, majority were female (99/92%), White (79/74%), Hispanic (55/51%) and had commercial insurance (29/27%) (table 1). The most common admission reason was infection (33/31%). Our rheumatology team evaluated 33 of the 107 patients during their first admission (31%). 29 (27%) patients were readmitted during our study period (figure 1).


Rheumatology follow-up was recommended for 35 patients (33%) on discharge. Of these 35 patients, 22 made their post-hospital rheumatology appointment, and only 4 were readmitted at a later time in our study period.  There were 72 patients (67%) who were not recommended follow-up on discharge. 24 of these patients were readmitted later in the study period. 77% of patients who made their initial post-hospitalization follow-up continued to follow at the clinic (figure 2).

Conclusion: This study provides insight into the care of SLE patients in our hospital system. It is reassuring that most patients who were recommended follow-up attended their appointment and continued to follow with an outpatient rheumatologist. Although SLE patients require complex coordination of care and need to see a rheumatologist on a regular basis, less than half of patients were recommended follow-up on discharge. Furthermore, those who were not recommended rheumatology follow-up were more likely to be readmitted compared to those who were. Now that this has been identified, our next step will be improve provider awareness of the importance of rheumatology follow-up in order to decrease readmission rates, and improve transitions of care for SLE patients with disadvantaged socioeconomic backgrounds.

Supporting image 1

Table 1: Demographic Data of 107 Hospitalized Patients with SLE

Supporting image 2

Figure 1: Reasons for Readmissions for 28 Readmitted SLE Patients

Supporting image 3

Figure 2: SLE Post-Hospitalization Outpatient Follow-up


Disclosures: R. Kotamarti: None; V. Patel: None.

To cite this abstract in AMA style:

Kotamarti R, Patel V. Characteristics of Hospitalizations and Outpatient Follow-up for Patients with SLE at an Academic Hospital Setting in Austin, Texas [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/characteristics-of-hospitalizations-and-outpatient-follow-up-for-patients-with-sle-at-an-academic-hospital-setting-in-austin-texas/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-hospitalizations-and-outpatient-follow-up-for-patients-with-sle-at-an-academic-hospital-setting-in-austin-texas/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology